The prevention and treatment strategies for heart failure (HF) have evolved in the past two decades. The stages of HF have been redefined, with recognition of the pre-HF state, which encompasses ...

Carnitines are essential components that transport long-chain fatty acids into myocardial mitochondria for β-oxidation to produce energy as a source of ATP generation [1, 2]. Serum acylcarnitine ...

Panelists discuss how effective heart failure management requires collaborative care across multiple specialties (primary care, cardiology, endocrinology, nephrology) with advanced practice providers ...

Heart failure (HF) remains a pressing health concern, with rising prevalence globally. Subjectivity and ambiguity in the ...

Patients hospitalized with a common form of heart failure could avoid later hospital stays—and dramatically lower health care costs—if they receive the full combination of four medications currently ...

Advanced heart failure is when heart failure progresses to the most severe stage. When you have advanced heart failure, your blood pressure, blood flow, kidney and liver function, exercise capacity, ...

This Journal feature begins with a case vignette highlighting a common clinical problem. Evidence supporting various strategies is then presented, followed by a review of formal guidelines, when they ...

Adults who have heart failure with a left ventricular ejection fraction of 40% or more face a high risk of hospitalization for heart failure and cardiovascular death. People who have heart failure ...

Belgrade, Serbia – 17 May 2025. An artificial intelligence-enabled electrocardiogram-based algorithm performed well in the early detection of heart failure among healthcare-seeking individuals in ...

Patients receiving cancer treatment often face the added complication of side effects affecting the heart, which can lead to the need to discontinue anticancer therapy, reducing its effectiveness.

The cardioprotective effects of heart failure treatments in patients with cancer were demonstrated today in a presentation at ...